Comparative Pharmacology
Head-to-head clinical analysis: DIAZEPAM versus LIBERVANT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIAZEPAM versus LIBERVANT.
DIAZEPAM vs LIBERVANT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Benzodiazepine that enhances GABA-A receptor activity by increasing the frequency of chloride channel opening, leading to neuronal hyperpolarization and inhibition.
GABA-A receptor positive allosteric modulator; enhances inhibitory neurotransmission.
Anxiety: 2-10 mg PO BID-QID; Sedation/Muscle spasm: 5-10 mg IV/IM q3-4h PRN; Status epilepticus: 0.15-0.2 mg/kg IV (max 10 mg) q10-15 min PRN.
0.25 mg intravenously over 2 minutes, may repeat once after 15 minutes if inadequate response; maximum total dose 0.5 mg.
None Documented
None Documented
Terminal half-life 30-56 hours (range 20-70 hours) in adults; prolonged in elderly (up to 100 hours), neonates (up to 100 hours), and cirrhosis (up to 100+ hours).
Clinical Note
moderateDiazepam + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Diazepam is combined with Fluticasone propionate."
Clinical Note
moderateFludiazepam + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Fludiazepam is combined with Fluticasone propionate."
Clinical Note
moderateDiazepam + Tenofovir disoproxil
"The metabolism of Tenofovir disoproxil can be decreased when combined with Diazepam."
Clinical Note
moderateTerminal elimination half-life is approximately 2–4 hours in patients with normal renal function; may be prolonged up to 8–12 hours in severe renal impairment (CrCl <30 mL/min).
Renal (70-80% as metabolites, primarily glucuronide conjugates; <5% unchanged), fecal (10-20% as metabolites), biliary (minor).
Primarily renal excretion of unchanged drug (approximately 85%) and glucuronide conjugates (approximately 10%); biliary/fecal excretion accounts for less than 5%.
Category D/X
Category C
Benzodiazepine
Benzodiazepine
Diazepam + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Diazepam."